eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJlbmNyeXB0ZWQiOiJleUpoYkdjaU9pSklVekkxTmlJc0luUjVjQ0k2SWtwWFZDSjkuZXlKcFpDSTZNak1zSW1WdFlXbHNJam9pY21WMlFHVnVkR2hsYnk1cGJtWnZJaXdpYVdGMElqb3hOekF5TXpjek5UUXdMQ0psZUhBaU9qTTNNakF4TURjd09EQjkuTEZ2M0JIbkhRLVBnTFFMdTJvcjNqdE91TlVHZC1peHp1LXlLN2Fodzc1dyIsImlhdCI6MTcwMjM3MzU0MCwiZXhwIjozNzIwMTA3MDgwfQ.0zJrErIRDbnQMn8pBNqFhzkGRNYpMwF9h5lwzn5BXdA Magic Myc https://mushgptawsbucket.s3.us-west-2.amazonaws.com/assets/static/mushGpt/mushGpt-chat-bot.png

How much would you like to donate?

$50 $100 $150

Thank you for donating to The Entheology Project.

Looks like there was a problem processing donation.

Home-based psilocybin treatment: A proposed pathway to access

By Rev

The Entheology Project’s aim to research pathways for accessing psilocybin can be broadly categorized into two approaches: home use with telemedicine support and standardized dosing, and supervised use by a therapist or western practitioner in person. Here, we outline the pros and cons of each, and suggest pathways that may become popular as demand grows.

  1. Home Use with Telemedicine Support and Standardized Dosing



Pathways for home use with telemedicine support and standardized dosing:

a) Online platforms: Develop an online platform that provides standardized doses of psilocybin, along with telemedicine support from trained professionals to ensure a safe and positive experience.

b) Partnerships with telehealth providers: Collaborate with existing telehealth providers to offer specialized services for psilocybin users, including standardized dosing and remote guidance.

  1. Supervised Use with a Therapist or Western Practitioner In Person



Pathways for supervised use by a therapist or western practitioner:

a) Specialized clinics: Establish dedicated psilocybin therapy centers with trained professionals to provide a safe and supportive environment for users.

b) Integration with existing mental health services: Integrate psilocybin-assisted therapy into existing mental health practices to offer a wider range of treatment options for patients.

As demand for psilocybin access grows, the popularity of these pathways will likely depend on factors such as cost, convenience, and the evolving legal landscape.

About Rev

“Rev” Hooman (Rev as in revelation) is the Founder of Entheology Project, a 508(c)(1)(a) Non-Profit Entheogenic Support Organization. We wrote MushGPT, a free entheogenic AI chatbot that raises entheo Seeker awareness. Please check out our projects and let us know how we can facilitate you! https://linktr.ee/therevhooman. 🍄❤️✌️

Read more Articles from Rev

PUBLIC SAFETY ALERT: Fentanyl Found In Recreational Drugs